Vitamin E in the treatment of tardive dyskinesia.
Eight subjects with persistent tardive dyskinesia were treated with vitamin E and placebo in a randomized, double-blind crossover study. Their mean score on the Abnormal Involuntary Movement Scale (AIMS) was significantly lower after treatment with vitamin E than after placebo administration.
AdolescentAdultAgedAntipsychotic AgentsDouble-Blind MethodDyskinesia, Drug-InducedFemaleHumansMaleMiddle AgedPlacebosPsychotic DisordersRandomized Controlled Trials as TopicVitamin E
Randomized Controlled Trial